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Osteogenesis imperfecta is a heterogeneous genetic disorder characterized by bone fragility. Previous research 
suggests that impaired collagen network and abnormal mineralization affect bone tissue properties, however, 
little data is yet available to describe bone material properties in individuals with this disorder. Bone material 
properties have not been characterized in individuals with the most common form of osteogenesis imperfecta, 
type I. 
Methods 
Bone tissue elastic modulus and hardness were measured by nanoindentation in eleven osteotomy specimens 
that were harvested from children with osteogenesis imperfecta during routine surgeries. These properties were 
compared between osteogenesis imperfecta types I (mild, n = 6) and III (severe, n = 5), as well as between 
interstitial and osteonal microstructural regions using linear mixed model analysis. 
Findings 
Disease severity type had a small but statistically significant effect on modulus (7%, P = 0.02) and hardness 
(8%, P < 0.01). Individuals with osteogenesis imperfecta type I had higher modulus and hardness than did those 
with type III. Overall, mean modulus and hardness values were 13% greater in interstitial lamellar bone regions 
than in osteonal regions (P < 0.001). 
Interpretation 
The current study presents the first dataset describing bone material properties in individuals with the most 
common form of osteogenesis imperfecta, i.e., type I. Results indicate that intrinsic bone tissue properties are 
affected by phenotype. Knowledge of the material properties of bones in osteogenesis imperfecta will 
contribute to the ability to develop models to assist in predicting fracture risk. 
Keywords 
Osteogenesis imperfecta, Bone, Material properties, Elastic modulus, Bone microstructure, Nanoindentation 
1. Introduction 
Osteogenesis imperfecta (OI) is a heterogeneous collagen-related genetic disorder resulting in bone fragility 
(Rauch and Glorieux, 2004, Sillence et al., 1979). Bone fragility in OI is thought to result from a combination of 
bone mass deficiency and compromised bone tissue material properties (Rauch and Glorieux, 2004, Roschger et 
al., 2008b, Weber et al., 2006). Little data, however, is yet available to describe bone material properties in 
individuals with OI (Fan et al., 2006, Fan et al., 2007a, Fan et al., 2007b, Weber et al., 2006). 
Severity of OI varies markedly, from mild to lethal in the perinatal period. OI types I–IV, representing the 
majority of individuals with OI, are dominant forms caused by defects in the quantity or structure of type I 
procollagen (Forlino et al., 2011, Smith, 1994). Other less common forms of OI have been identified recently. 
These include another autosomal dominant form (OI type V) for which the gene defect is unknown, and six 
recessive forms attributed to deficiency of proteins that affect post-translational modification or folding of 
collagen (Forlino et al., 2011). In the current study, intrinsic bone material properties were compared between 
young individuals with two very distinct forms of OI: type I, the mildest form which tends to result in fewer 
fractures and near normal stature and physical function; and type III, a severe form that often leads to more 
frequent fractures and progressive skeletal deformities (Sillence et al., 1979). 
Structural and material bone abnormalities have been noted in OI. From a structural perspective, individuals 
with OI tend to have low bone mass. Histomorphometric analyses have noted lower cortical thickness and 
decreased trabecular bone volume per tissue volume in children with OI (Rauch et al., 2000, Roschger et al., 
2008a). 
At the ultrastructural level, the diameters of type I collagen fibrils in OI bone have been reported to differ from 
those of typical bone (Cassella et al., 1994, Stoss and Freisinger, 1993). With respect to the inorganic content of 
bone, mineral content and the shape, size and composition of the mineral crystals can also be altered with OI 
pathologies (Traub et al., 1994, Vetter et al., 1991). Calcium to phosphorus (Ca/P) ratio was observed to be 
lower than normal in OI bone (Cassella and Ali, 1992, Cassella et al., 1995). It was also found that average bone 
mineralization density tends to be higher than normal in OI (Boyde et al., 1999, Roschger et al., 2008a, Weber et 
al., 2006). 
These abnormalities in collagen and bone mineral crystals suggest that the intrinsic, i.e., tissue-level, bone 
material behavior is compromised in OI. Limited data, however, is yet available to describe bone material 
properties in individuals with OI. A few studies have used nanoindentation to characterize bone in severe (type 
III) and moderately severe (type IV) OI (Fan et al., 2006, Fan et al., 2007a, Fan et al., 2007b, Weber et al., 2006). 
In nanoindentation, a diamond-tip indenter is pressed into the polished surface of a specimen, typically a few 
hundred nanometers deep, enabling local measurements of elastic modulus and hardness (Lewis et al., 
2006, Weber et al., 2006). These properties were found to be higher in children with severe OI than in age-
matched controls (Weber et al., 2006), however, no significant differences were reported between moderate 
and severe OI (Fan et al., 2007a, Fan et al., 2007b). No data is yet available to describe bone material properties 
in individuals with the most common form of OI, type I. 
It is worth noting that wide ranges of values in elastic modulus (11–24 GPa) and hardness (0.3–0.9 GPa) have 
been reported for severe OI (Fan et al., 2006, Fan et al., 2007a, Fan et al., 2007b, Weber et al., 2006). Variability 
between these studies may be attributed in part to the selection of indentation sites. Previous studies have 
indicated that these properties tend to be higher in interstitial than osteonal bone regions (Hoffler et al., 
2005, Rho and Pharr, 1999). 
The primary question of this study was: do the material properties of bone differ between individuals with OI 
types I (mild OI) and III (severe OI)? The secondary question was: how do properties vary between regions of 
interstitial and osteonal bone? These questions were investigated using small bone specimens from children 
with OI, collected during routine surgical procedures. 
2. Methods 
This study investigated the effects of disease severity (phenotype) on the local elastic modulus and hardness of 
bone tissue from children with OI types I and III, using nanoindentation. The effect of the choice of indentation 
site on the measured properties was also investigated. 
2.1. Specimens 
Bone specimens were collected from lower extremity long bones of young individuals with OI. Inclusion criteria 
were: pediatric patients between 5 and 18 years of age with OI types I and III, and who are undergoing routine 
surgery at Shriners Hospitals for Children – Chicago for fracture repair and/or deformity correction of lower 
extremity long bones. Bone specimens selected for this study had a lamellar microstructure, without the 
appearance of callous tissue. A total of twelve bone specimens were collected for this study, of which one 
specimen was excluded due to the presence of callous tissue and a lack of lamellar microstructure, indicating 
remodeling activity at a fracture site. Eleven bone specimens, obtained from ten donors, were therefore 
included in this study. Five of the donors (ages 7–16) had the mildest form, OI type I, while the other five (ages 
7–14) had a more severe form, type III (Table 1). Donor ages did not differ significantly between the two groups 
(Student's t-test, P = 0.5). The specimens were obtained under appropriate informed consent and IRB approval 
(#10101309 from Rush University Medical Center, and #HR-2167 from Marquette University). The unfixed 
specimens were stored at − 85°C until testing. A previous study found that storage at a similar temperature 
(− 80°C) for up to 5 years did not have significant effects on histological features or mechanical properties of 
bones (Salai et al., 2000). 
Table 1. Specimen descriptions: Donor age, gender, OI type, history of bisphosphonate treatment, and anatomic 
site. 








1 I 16 M Tibia (p.d.) Yes 10 10 
2 I 7 F Tibia (m.d.) Yes 11 0 
3⁎ I 14 F Tibia (m.d.) Yes 9 3 
4 I 13 M Femur (m.d.) Yes 7 9 
5⁎ I 11 F Femur (p.d.) Yes 8 10 
6 I 15 M Femur (d.d.) Yes 0 8 
7 III 12 M Tibia (m.d.) No 5 9 
8 III 12 M Tibia (m.d.) No 2 14 
9 III 14 M Tibia (m.d.) Yes 14 5 
10 III 7 F Tibia (m.d.) No 5 6 
11 III 12 F Femur (p.d.) Yes 13 10 
(p.d.) Proximal diaphysis; (m.d.) middle diaphysis; and (d.d.) distal diaphysis. 
⁎Specimens 3 and 5 were obtained from the same donor during surgical procedures that were performed three 
years apart. 
 
2.2. Specimen preparation 
Prior to nanoindentation, the specimens were thawed and prepared for embedding. The specimens were cross-
sectioned under constant water irrigation using a diamond saw (IsometTM Low Speed Saw; Buehler, Lake Bluff, 
IL, USA). The cross-sections were oriented such that the exposed surface was approximately perpendicular to 
the longitudinal axis of the long bone, using the periosteal surface of the specimen as a reference. The 
specimens were fixed and dehydrated in graded ethanol solutions: 70%, 24 h; 80%, 2 h; 95%, 2 h; 95%, 3 h; 
100%, 2 h; 100%, 2 h; and 100%, 3 h. After dehydration, the specimens were air-dried for approximately 5 min 
and embedded under vacuum in a low viscosity epoxy resin (Epo-Thin®; Buehler, Lake Bluff, IL, USA). After 
polymerization, the specimen surfaces were ground on a grinder–polisher (Metaserv® 3000; Buehler, Lake Bluff, 
IL, USA) using progressively fine grit sizes: 400, 600, 800, and 1200. The surfaces were polished using a 3 μm 
aluminum oxide coated disc (Fibrmet®; Buehler, Lake Bluff, IL, USA). Final polishing was done with a polishing 
cloth (Microcloth®; Buehler, Lake Bluff, IL, USA) and a 0.05 μm alumina suspension (Micropolish® B; Buehler, 
Lake Bluff, IL, USA). 
2.3. Nanoindentation testing 
Testing was performed on a nanoindenter (Nano Indenter XP; MTS, Eden Prairie, MN, USA), using a Berkovich 
diamond indenter tip. Measurements of modulus and hardness were obtained using the Continuous Stiffness 
Measurement (CSM) algorithm that was associated with the nanoindenter. The CSM algorithm applies a low 
magnitude oscillating force superimposed onto the nominally increasing load (Li and Bhushan, 2002). This 
method has been used by others in the characterization of bone material properties (Wang et al., 2008a, Wang 
et al., 2008b). With this test method, the indenter penetrates the specimen surface with a defined frequency, 
amplitude, strain rate and maximum depth. Modulus and hardness are measured continuously as a function of 
penetration depth. Frequency and amplitude were set at 45 Hz and 2 nm, respectively, as was done in previous 
studies (Wang et al., 2008a, Wang et al., 2008b). A strain rate of 0.05 s− 1, and a depth limit of 2000 nm were 
used. As in previous studies, Poisson's ratio was assumed to be 0.3 for the bone specimens (Fan et al., 2006, Fan 
et al., 2007a, Wang et al., 2008a, Wang et al., 2008b). Modulus and hardness were calculated automatically as a 
function of indentation depth using the CSM algorithm. For each indent, average modulus and hardness values 
were obtained between indentation depths of 800–1600 nm, a range over which these measurements were 
approximately constant. 
A total of 20 indents per specimen were performed. For each specimen, indentation was performed in four 
separate, pre-defined clusters, each located in a different region of lamellar bone. Bone microstructure was 
described at each indent site using an optical microscope. The indent sites were divided in two microstructural 
groups: osteonal bone and interstitial lamellar bone. Typical indent sites are shown in Fig. 1. Microstructure at 
each indentation site was identified by two independent observers (JJ and CA). Data points for which the two 
observers did not agree on the type of lamellar microstructure were excluded from the data set. Indents that 
were found to be in contact with void spaces such as osteocyte lacunae, resorption spaces and Haversian canals 
were also excluded from the dataset. Finally, indents that were located in non-lamellar bone (e.g., woven bone), 
and those for which the site could not be distinguished clearly as being located in osteonal or interstitial bone 
regions were also excluded. 
 
Fig. 1. Location of typical indentation sites. (A) Osteonal bone region. (B) Interstitial lamellar bone region. The 
bone cross section shown was obtained from the femoral diaphysis of a 16-year-old male with OI type I. 
A total of 168 indents were included in this study. Approximately half (85) of the indents were in the specimens 
of OI type I, while the others (83) were in those of type III. Half of the indents (84) were located in interstitial 
lamellar bone. The other half of the indents were in osteonal regions (Table 1). 
2.4. Statistical analysis 
The effects of disease severity (OI types I vs. III) and lamellar microstructure (osteonal vs. interstitial) on local 
elastic modulus and hardness were analyzed statistically using linear mixed effects models. The statistical 
analysis was performed by a statistician using an open source software package (The R Project for Statistical 
Computing, www.r-project.org). OI severity and microstructure were defined as fixed factors in the model. 
Specimen number (1–11) was treated as a random factor. The effects of four potential covariates were also 
explored: patient age, patient gender, anatomic site (femur or tibia), and patient history of bisphosphonate 
treatment (yes or no). Covariates that were found to be significant (P < 0.05) were included in the final statistical 
models. 
3. Results 
Modulus and hardness results for each OI type (I and III) are shown in Fig. 2. Within each OI severity group, the 
results are presented for each microstructure (interstitial and osteonal) in Fig. 2. 
 
Fig. 2. Elastic modulus (left) and hardness (right) results for all indents. Results for OI type I are shown as 
diamonds: interstitial (  ) and osteonal bone regions (♢). Results for OI type III are shown as circles: interstitial 
(●) and osteonal regions (○). Shown are means and standard deviations. *P < 0.05 between OI types I and III, 
based on linear mixed effects models (see Table 2, Table 3). 
3.1. Building of statistical model for modulus 
Of the possible covariates investigated, only anatomic site (tibia vs. femur) had a significant effect on modulus 
(P = 0.014) and was retained for the final statistical model. The other possible covariates, i.e., donor age, gender 
and history of bisphosphonate treatment, did not have a significant effect on modulus (P > 0.05). Therefore, 
these factors were not included in the final model. 
3.2. Results of statistical model for modulus 
The results of the final linear mixed model for modulus are presented in Table 2. Based on the model results, OI 
disease severity had a significant effect on modulus (P = 0.024). Individuals with OI type III had lower moduli 
than did those with type I by approximately 7% (16.3 GPa vs. 17.5 GPa). Bone microstructure also had a 
significant effect on modulus (P < 0.001), with osteonal bone having lower modulus than interstitial lamellar 
bone by approximately 13%. Finally, the effect of anatomic site was also significant (P = 0.014) with the modulus 
being higher in the tibia than the femur by approximately 8%. 








(OI type I, interstitial bone, femur) 
17.53 0.47 < 0.001 
Severity = OI type III − 1.23 0.55 0.024 
Microstructure = Osteonal − 2.21 0.28 < 0.001 
Anatomic site = Tibia 1.40 0.57 0.014 
 
3.3. Building of statistical model for hardness 
With respect to the hardness model, two covariates were found to have statistically significant effects: patient 
gender and history of bisphosphonate treatment (P < 0.05). Therefore, these two factors were included as 
covariates in the final model for hardness. 
3.4. Results of statistical model for hardness 
Results of the linear mixed model for hardness are presented in Table 3. As seen in Table 3, OI severity had a 
significant effect on bone tissue hardness (P = 0.003), OI type III having lower hardness than OI type I by 8%. 
Bone microstructure also had a significant effect (P < 0.001), with osteonal bone having lower hardness than 
interstitial bone by 11%. Finally, hardness was higher for males than females by 6%, and individuals with a 
known history of bisphosphonate treatment prior to tissue donation had a lower hardness by 6% (P < 0.04). 








(OI type I, interstitial bone, female) 
0.656 0.026 < 0.001 
Severity = OI type III − 0.054 0.018 0.003 
Microstructure = osteonal − 0.735 0.013 < 0.001 
Gender = male 0.041 0.015 0.006 
Bisphosphonates = yes − 0.044 0.021 0.039 
 
4. Discussion 
Little data is currently available to describe the material properties of bones in individuals with OI, and bone 
material properties have not yet been characterized for the most common form, OI type I. The primary goal of 
this study was to determine if bone material properties differ between individuals with OI types I and III. This 
question was investigated using nanoindentation. To determine the role (if any) of microstructure, these 
properties were also compared between interstitial and osteonal bone regions. 
Osteotomy specimens are often sent for routine histopathology or discarded following orthopedic surgeries in 
children with OI. These specimens can provide a valuable resource for characterizing bone material behavior. 
Because of its small scale, nanoindentation lends itself well to the testing of these osteotomy specimens. 
Nevertheless, use of this technique to characterize bone tissue has some limitations. Calculation of elastic 
modulus assumes local isotropy of the mechanical properties of the bone specimens, which may not be true. A 
previous nanoindentation study of OI bone, however, did not find significant modulus differences between 
longitudinal and transverse directions, suggesting that OI bone tissue at the sub-microstructural scale may be 
more isotropic than healthy bone tissue (Fan et al., 2006). Modulus calculation in nanoindentation also requires 
knowledge of the specimen's Poisson's ratio. In the present study, a Poisson's ratio of 0.3 was assumed. Varying 
Poisson's ratio of bone specimens as input from 0.2 to 0.4 was reported to affected modulus results by 8–9% 
(Hoffler et al., 2005, Turner et al., 1999). Moreover, bone tissue behavior is viscoelastic in nature, and 
experimental factors such as specimen dehydration (Hengsberger et al., 2002, Hoffler et al., 2005, Rho and 
Pharr, 1999), loading rate (Hoffler et al., 2005, Mittra et al., 2006), specimen mounting media (Mittra et al., 
2006) and time of storage before testing (Mittra et al., 2006) have been demonstrated to affect modulus 
measured by nanoindentation. For example, it is a common practice to fix and dehydrate the bone specimens 
prior to nanoindentation (Fan et al., 2007a, Isaksson et al., 2010, Mittra et al., 2006, Mulder et al., 2007, Turner 
et al., 1999) in order to facilitate handling, storage, and testing. Modulus of bone measured by nanoindentation, 
however, was found to be higher under dry vs. wet conditions (Bushby et al., 2004, Guidoni et al., 2010, Hoffler 
et al., 2005), and this phenomenon has been attributed to the contribution of the non-mineralized phase 
(Guidoni et al., 2010). To minimize undue experimental variability between the specimens, dehydration 
protocol, embedding media, time of storage (2 weeks prior to testing), and loading rate were kept constant in 
this study. Nonetheless, in light of the abovementioned limitations that are inherent to the use of 
nanoindentation to characterize bone tissue, emphasis of the current results should be placed on the relative 
effects of the factors rather than on the absolute values. 
Another limitation in this study is the small number of specimens in each OI type. As in any small sample study, 
the reliability of the statistical conclusions is hindered by the small number of specimens, and a heavy reliance 
on the chosen statistical models is required. 
The results of the present study were within the range of values reported in previous nanoindentation studies of 
OI bone (Fan et al., 2006, Fan et al., 2007a, Fan et al., 2007b, Weber et al., 2006). Current results for osteonal 
regions of OI type III were similar to those of another study in which the indentation sites were also located 
within osteons (Fan et al., 2006). For interstitial regions, previously published average results for modulus (19–
22 GPa) and hardness (0.7–0.8 GPa) for severe OI were somewhat higher than the current results (Fan et al., 
2007a, Weber et al., 2006). These differences may be attributed to the abovementioned experimental factors, 
differences between anatomic site (iliac crest vs. long bones), and/or differences in indentation sites within 
interstitial bone. 
The main finding of this study was that OI severity had a small but significant effect on the material properties 
measured. Elastic modulus and hardness were higher in individuals with OI type I than in those with type III. The 
reason behind this observation is not fully understood. It has been postulated that the higher modulus 
previously reported in severe OI compared to normal bone (Weber et al., 2006) could be attributed to a more 
highly mineralized bone matrix (Roschger et al., 2008a). A relationship between local modulus and local 
mineralization has indeed been observed in previous studies of animal (Burket et al., 2011, Hoc et al., 2006) and 
human bones (Smith et al., 2010). A scanning electron microscopy study found that mean bone mineralization 
density of iliac crest biopsies was higher in children with OI than in normal controls and it was further noted that 
mineralization density tended to be lower in OI type I than in OI types III–V (Boyde et al., 1999). The current 
finding of higher elastic modulus and hardness in OI type I than in type III is therefore surprising in that it does 
not seem to fit the assumption that a higher modulus is attributed to higher mineralization. Nonetheless, in a 
recent nanoindentation study in a mouse model for OI (oim), modulus was not found to correlate with local 
measurements of bone matrix mineralization (Vanleene et al., 2012). Therefore, the effect of OI severity on 
modulus and hardness may be related to factors other than mineralization density, such as: size, shape and 
composition of the mineral crystals, collagen structure, and/or mechanical interaction between the collagen 
fibrils and the mineral crystals. 
On the collagen side, OI type I is typically associated with a null COL1A1 mutation that results in a reduced 
production of type I collagen (Barsh et al., 1982, Willing et al., 1992, Willing et al., 1996). In OI type I, collagen is 
normal in composition and structure but an insufficient quantity is produced (Barsh et al., 1982, Smith, 1994). OI 
type III, on the other hand, is associated with amino substitution defects within type I collagen molecules, i.e., 
collagen quality is affected rather than its quantity (Forlino et al., 2011, Smith, 1994). These qualitative collagen 
mutations could affect the mechanical behavior of the collagen fibril differently than quantitative ones (OI type 
I). For example, a computational study has demonstrated that structural mutations within type I collagen 
molecules could compromise fibril mechanical properties by altering stress distribution within the fibrils 
(Gautieri et al., 2009). At the ultrastructural level, abnormal type I collagen fibril diameters have been reported 
in OI, although there is disagreement as to whether their diameters are higher (Cassella and Ali, 1992, Cassella 
et al., 1994) or lower (Stoss and Freisinger, 1993) than normal. Conflicting information also exists when 
comparing the fibril diameters between phenotypes. One study noted that fibril diameter tended to be larger in 
OI type I and smaller in OI type IV (Cassella and Ali, 1992), while another reported the opposite, i.e., that fibril 
diameter was smaller in OI type I than in types III and IV (Stoss and Freisinger, 1993), although no statistical 
analysis supported this observation. 
On the mineral side, compositional and structural abnormalities have also been reported in OI bone. Ca/P ratio 
was found to be lower than normal in OI, although phenotypes were not compared (Cassella and Ali, 
1992, Cassella et al., 1995). Apatite crystals were also found to be smaller than normal in children with OI and 
their size was noted to decrease with disease severity (Traub et al., 1994, Vetter et al., 1991). Similar 
observations were also reported in animal models of OI (Fisher et al., 1987, Fratzl et al., 1996, Grabner et al., 
2001, Vanleene et al., 2012). Further work is warranted to investigate the roles of local bone tissue composition 
and ultrastructure on the mechanical properties of bone in humans with OI. 
The current study presents the first mechanical characterization of bone tissue in humans with OI type I. 
Although the study did not include a normal control group, the results can be compared against those of other 
previously published studies to get a sense of how modulus compares between OI phenotypes and normal bone. 
A few studies have looked at tensile and flexural mechanical properties of pediatric bone at the mesoscale 
(Currey and Butler, 1975, Hirsch and Evans, 1965). Modulus results from the current study lie within the range of 
moduli previously for pediatric bone specimens (Hirsch and Evans, 1965), however, it could be misleading to 
compare results obtained by nanoindentation directly to control values obtained at the mesoscale. Moduli of 
normal as well as OI pediatric iliac crest biopsies have been measured by nanoindentation (Weber et al., 2006). 
However, modulus values for severe OI in that study were higher than those of the current study. This 
discrepancy is likely due to differences in indentation site or other experimental factors, as discussed earlier. For 
this reason, cross-study comparisons of these nanoindentation results should be based on relative observations 
rather than absolute values. While no significant difference in elastic modulus has been found between 
individuals with OI types III and IV (Fan et al., 2007a, Fan et al., 2007b), modulus was 13% higher in iliac crest 
biopsies from children with severe OI than in age-matched normal controls (Weber et al., 2006). One might 
expect the elastic modulus of bone in milder OI (type I) to fall between those of severe OI (type III) and normal 
tissue, however, results of the current study indicate that this might not be the case (Fig. 3). In the current study, 
elastic modulus was slightly higher in OI type I than in type III. As discussed previously, further research is 
required to explain this observation. 
 
Fig. 3. Synthesis of the effects of OI type on the elastic modulus of human bone tissue by nanoindentation: 
comparison of the relative results of the current study to those of previous studies of pediatric OI bone. 
Studies in mice have also produced uncertainties regarding the effect of OI on the elastic modulus of bones. 
Some mechanical studies of whole bones reported higher modulus in oim/oim mice, representative of severe OI, 
than in wild-type control littermates (Miller et al., 2007, Misof et al., 2005, Rao et al., 2008), while no significant 
difference was seen in another study (McCarthy et al., 2002). On the other hand, oim mice were found to have 
lower modulus by nanoindentation than their wild-type littermates (Vanleene et al., 2012). For the Mov13 mice, 
which produce bone pathology analogous to mild OI, elastic modulus was reported to be higher than that of 
control littermates in the anterior femoral region, but not in the posterior region (Jepsen et al., 1997). The 
present study indicates that, at the sub-microstructural level, average elastic modulus is slightly greater in 
individuals with mild OI than in those with a severe form of the disorder. 
Bone microstructure had a significant effect on both modulus and hardness. These properties were higher in 
interstitial lamellar regions than in osteonal regions. Similar results were reported in other nanoindentation 
studies of bovine (Rho and Pharr, 1999) and adult human bones (Hoffler et al., 2005, Rho et al., 2002). These 
differences are likely attributed to differences in degrees of mineralization between these regions. Osteonal 
regions tend to be less mineralized than interstitial bone (Eschberger and Eschberger, 1986), and a relationship 
has been observed between local bone modulus and degree of mineralization (Gupta et al., 2005, Mulder et al., 
2007, Tai et al., 2005). 
Elastic modulus and hardness measure resistance to elastic (recoverable) and localized plastic (irrecoverable) 
deformation, respectively. Although they represent distinct properties, a relationship exists between them in 
bone tissue. In the current study, hardness results correlated positively with modulus (Pearson's correlation, 
slope = 0.038, R2 = 0.80, P < 0.001). This relationship is consistent with previous studies, and it has been 
attributed to these two properties having similar relationships with local bone mineral content (Currey and 
Brear, 1990, Hodgskinson et al., 1989, Hoffler et al., 2005). 
Bisphosphonates have become commonly used in the treatment of children with OI, as a means to reduce 
fracture risk by increasing bone mass (Rauch and Glorieux, 2004). Most but not all of the individuals who 
donated the bone specimens used in this study had a known history of bisphosphonate treatment. This factor 
was not controlled in our study design; nonetheless the significance of its association with the measured 
properties was explored. In a previous study of OI bone, hardness and modulus were not found to be affected 
after two to three years of pamidronate treatment (Weber et al., 2006). In the current study, history of 
bisphosphonate treatments had no significant effect on modulus, but a small significant effect on hardness was 
observed. Therefore, some material properties may indeed be affected by the use of bisphosphonates. It should 
also be emphasized that bone material strength or toughness were not measured in these nanoindentation 
studies, and that the effect of bisphosphonates on those properties has not yet been determined. 
Bisphosphonates inhibit osteoclasts, which play an important role in the cortical bone remodeling process. 
Consequently, this class of drugs may adversely affect the material strength and toughness of cortical bone 
tissue. Nevertheless, as previously stated by Weber et al., a reduction in fracture incidence after pamidronate 
use in OI is likely attributed to an increase in bone mass rather than to changes in bone material properties 
(Weber et al., 2006). 
In the present study, modulus was slightly higher in the tibia than the femur. A similar observation was also 
reported in a macroscopic-scale tensile study of human bone specimens (Burstein et al., 1976). Males also had 
slightly higher bone tissue hardness than did females, although the meaning behind this observation is not clear. 
No difference in modulus was seen between the genders, and this observation is in agreement with the results 
of a previous study (Lindahl and Lindgren, 1967). 
The structural behavior of whole bones is dependent not only on material properties but on geometry as well. 
Histological studies have shown that individuals with severe OI tend to have less bone tissue than those with 
mild OI, as evidenced by thinner cortices and decreased trabecular bone volume (Rauch et al., 2000). Therefore, 
due to a combination of decreased bone volume and lower tissue modulus, the overall structural stiffness of 
whole bones could be appreciably lower in individuals with severe OI than in those with mild OI. 
5. Conclusions 
Results of the present study indicate that bone material properties are affected by OI severity, and that modulus 
and hardness are higher in individuals with OI type I than type III. Based on the current findings, it would be ideal 
if future studies aimed at characterizing the mechanical properties of bones in OI considered each phenotype 
separately. Further research is recommended to determine how other material properties, such as bone 
material strength and toughness, are affected by OI severity and by bisphosphonate treatments. Knowledge of 
these bone material properties in OI will contribute to the ability to develop models to assist in predicting 
fracture risk. 
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